Metraipolis › archive › dc_d54056437dde

Design, synthesis and biological activity of glycoconjugated ADAMTS5 exosite inhibitors: applications in osteoarthritis and ovarian cancer models — Europe PMC PMID:41381706

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41381706
DOI
10.1038/s41598-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-11-07T17:14:37.619Z
SHA-256 of the archived text
960c23ceb35a4a581cfe0758f4c4778eb066dda2c422ef4d21b519a91f34c75d
Stable URL of this page
https://metraipolis.com/documento/dc_d54056437dde

How to cite

Design, synthesis and biological activity of glycoconjugated ADAMTS5 exosite inhibitors: applications in osteoarthritis and ovarian cancer models — Europe PMC PMID:41381706 — Europe PMC (en), https://europepmc.org/article/MED/41381706 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d54056437dde (Metraipolis archive dc_d54056437dde, sha256 960c23ceb35a4a581cfe0758f4c4778eb066dda2c422ef4d21b519a91f34c75d)
BibTeX
@misc{dcd54056437dde,
  title = {Design, synthesis and biological activity of glycoconjugated ADAMTS5 exosite inhibitors: applications in osteoarthritis and ovarian cancer models — Europe PMC PMID:41381706},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41381706},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d54056437dde; sha256 960c23ceb35a4a581cfe0758f4c4778eb066dda2c422ef4d21b519a91f34c75d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41381706. Agents can read the archived copy with the MCP tool read_document.